EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo‐Controlled Study

Jeanne Morency iD, Éric Troncy iD, Aliénor Delsart iD, Colombe Otis iD, Jérôme R E Del Castillo iD, Andrea Gonzales, Jason Ross, Maxim Moreau, Jean-Pierre Pelletier iD, Johanne Martel-Pelletier, Frédéric Sauvé iD

Veterinary Dermatology · 2025

DOI: 10.1111/vde.70000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Dermatology, 2025. Verfasst von Jeanne Morency und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, Canada. Hauptthemen laut MEDLINE: Gabapentin, Prednisolone, Cyclosporine, Cat Diseases. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zoetis, Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gabapentin reportedly decreases central sensitisation, a disorder associated with chronic pruritus in humans, although this is not well documented in cats. Its combined use with the standard antipruritic therapy for feline atopic skin syndrome (FASS) is not yet described.

Objectives

To evaluate the impact of prednisolone, ciclosporin or placebo, with or without gabapentin, on lesional scores and actimetry in FASS cats. Animals Twenty‐six cats from a laboratory colony with naturally acquired FASS. Methods and Materials Following a 12‐week washout period, cats were allocated to one of three groups: prednisolone (1 mg/kg, n = 9), ciclosporin (7 mg/kg, n = 8) and placebo (Avicel, n = 9). Treatments were administered orally, once daily for 5 weeks (Week [W]0 to W4), then combined with gabapentin (10–15 mg/kg) for another 3 weeks. The Feline Dermatitis Extent and Severity Index (FeDESI) was assessed at baseline and W2, W4 and W7. Actimetry was recorded and analysed over weekend (WE) time points. A repeated‐measures generalised mixed model was applied using the zero‐inflated negative binomial (FeDESI) or log‐normal (actimetry) distribution ( α = 0.05).

Results

Prednisolone alone significantly improved FeDESI ( p = 0.008), while ciclosporin required the addition of gabapentin to achieve a significant effect ( p < 0.034). Gabapentin decreased FeDESI scores in all groups ( p < 0.001) and demonstrated the highest incidence rate ratio (2.59) compared to placebo. Improvements in FeDESI were associated with significant (corresponding in intensity) decreases in motor activity. Conclusions and Clinical Relevance Gabapentin, particularly when combined with prednisolone or ciclosporin, may reduce lesional score and actimetry‐assessed itch in FASS cats, suggesting a potential central sensitisation in some cats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GabapentinPrednisoloneCyclosporineCat DiseasesDermatitis, AtopicAnimalsCatsFemaleMaleProspective StudiesDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

anti‐hyperalgesicfelinegabapentinoidimmune modulationitchpruritus

Substanzen

GabapentinPrednisoloneCyclosporine

Autor:innen und Institutionen

  • Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, Canada.
  • Groupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), St-Hyacinthe, Canada.
  • Zoetis, Kalamazoo, Michigan, USA.
  • Osteoarthritis Research Unit, CHUM Hospital Research Centre (CRCHUM), Montréal, Canada.

ORCID-Profile: Jeanne Morency, Éric Troncy, Aliénor Delsart, Colombe Otis, Jérôme R E Del Castillo, Jean-Pierre Pelletier, Frédéric Sauvé

Förderung

  • Zoetis
  • Natural Sciences and Engineering Research Council of Canada
  • Canada Foundation for Innovation
  • Mitacs

Zitieren

APA

Morency, J., Troncy, É., Delsart, A., Otis, C., Del Castillo, J. R. E., Gonzales, A., Ross, J., Moreau, M., Pelletier, J. P., Martel-Pelletier, J., & Sauvé, F. (2025). Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo‐Controlled Study. Veterinary Dermatology. https://doi.org/10.1111/vde.70000

Vancouver

Morency J, Troncy É, Delsart A, Otis C, Del Castillo JRE, Gonzales A, et al. Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo‐Controlled Study. Veterinary Dermatology. 2025. doi:10.1111/vde.70000

BibTeX
@article{Morency2025,
  author = {Morency, Jeanne and Troncy, Éric and Delsart, Aliénor and Otis, Colombe and Del Castillo, Jérôme R E and Gonzales, Andrea and Ross, Jason and Moreau, Maxim and Pelletier, Jean-Pierre and Martel-Pelletier, Johanne and Sauvé, Frédéric},
  title = {Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo‐Controlled Study},
  journal = {Veterinary Dermatology},
  year = {2025},
  doi = {10.1111/vde.70000}
}
Kostenlos starten →